{"title":"Effects of bisphenol A and bisphenol S on human fallopian tube contractions: An in vitro and in silico study","authors":"Richa Singh , Parul Sharma , Sakshi Agarwal , Shristi Modanwal , Sushmitha Paulraj , Sanjeev Kumar Mahto","doi":"10.1016/j.reprotox.2026.109211","DOIUrl":null,"url":null,"abstract":"<div><div>Bisphenol A (BPA), a widely used industrial compound, and its structural analogue Bisphenol S (BPS) are known to exert reproductive toxicity. However, their direct impact on human fallopian tube contractility remains unexplored. This study aimed to investigate the effects of BPA and BPS on spontaneous smooth muscle contractions of the human fallopian tube. Fallopian tube samples from the proliferative phase were used for in vitro contractility assays. The effects of BPA and BPS (1–20 µM) on maximum contractile strength (MCS), basal tone (BT), and contraction frequency (CF) were recorded and analyzed using ANOVA. Cytotoxicity of both compounds was assessed in MCF-7 cells using the MTT assay. Molecular docking examined BPA and BPS binding affinities to key receptors. Both BPA and BPS significantly reduced contractile activity in a concentration-dependent manner (p < 0.001), with BPA exhibiting a stronger inhibitory effect than BPS. MTT assays demonstrated a significant dose- and time-dependent decrease in cell viability for both compounds. Molecular docking indicated comparable binding affinities of BPA and BPS toward estrogen, progesterone, oxytocin, prostaglandin, and calcium channel receptors. BPA and BPS impair human fallopian tube contractility and exhibit cytotoxicity. These findings highlight potential reproductive risks associated with exposure to bisphenol compounds and underscore the need for subsequent extensive studies.</div></div>","PeriodicalId":21137,"journal":{"name":"Reproductive toxicology","volume":"142 ","pages":"Article 109211"},"PeriodicalIF":2.8000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive toxicology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0890623826000547","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/7 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"REPRODUCTIVE BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Bisphenol A (BPA), a widely used industrial compound, and its structural analogue Bisphenol S (BPS) are known to exert reproductive toxicity. However, their direct impact on human fallopian tube contractility remains unexplored. This study aimed to investigate the effects of BPA and BPS on spontaneous smooth muscle contractions of the human fallopian tube. Fallopian tube samples from the proliferative phase were used for in vitro contractility assays. The effects of BPA and BPS (1–20 µM) on maximum contractile strength (MCS), basal tone (BT), and contraction frequency (CF) were recorded and analyzed using ANOVA. Cytotoxicity of both compounds was assessed in MCF-7 cells using the MTT assay. Molecular docking examined BPA and BPS binding affinities to key receptors. Both BPA and BPS significantly reduced contractile activity in a concentration-dependent manner (p < 0.001), with BPA exhibiting a stronger inhibitory effect than BPS. MTT assays demonstrated a significant dose- and time-dependent decrease in cell viability for both compounds. Molecular docking indicated comparable binding affinities of BPA and BPS toward estrogen, progesterone, oxytocin, prostaglandin, and calcium channel receptors. BPA and BPS impair human fallopian tube contractility and exhibit cytotoxicity. These findings highlight potential reproductive risks associated with exposure to bisphenol compounds and underscore the need for subsequent extensive studies.
期刊介绍:
Drawing from a large number of disciplines, Reproductive Toxicology publishes timely, original research on the influence of chemical and physical agents on reproduction. Written by and for obstetricians, pediatricians, embryologists, teratologists, geneticists, toxicologists, andrologists, and others interested in detecting potential reproductive hazards, the journal is a forum for communication among researchers and practitioners. Articles focus on the application of in vitro, animal and clinical research to the practice of clinical medicine.
All aspects of reproduction are within the scope of Reproductive Toxicology, including the formation and maturation of male and female gametes, sexual function, the events surrounding the fusion of gametes and the development of the fertilized ovum, nourishment and transport of the conceptus within the genital tract, implantation, embryogenesis, intrauterine growth, placentation and placental function, parturition, lactation and neonatal survival. Adverse reproductive effects in males will be considered as significant as adverse effects occurring in females. To provide a balanced presentation of approaches, equal emphasis will be given to clinical and animal or in vitro work. Typical end points that will be studied by contributors include infertility, sexual dysfunction, spontaneous abortion, malformations, abnormal histogenesis, stillbirth, intrauterine growth retardation, prematurity, behavioral abnormalities, and perinatal mortality.